Nav1.8 inhibitor (experimental)

· Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nav1.8 inhibitor (experimental), covering 2025-04-20 to 2025-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Microneurography Study of NaV1.8 Inhibition in Healthy Adults [Phase 1]